After 50% or more share price growth, should you sell these ASX 200 winners?

MotleyFool
Aug 08

A selection of S&P/ASX 200 Index (ASX: XJO) shares delivered more than 50% share price growth in FY25.

Investors were thrilled, but after such strong growth, should they consider selling and taking some profits?

Market analysts share their insights on this group of ASX 200 winners.

What to do now with these surging ASX 200 shares

Zip Co Ltd (ASX: ZIP)

The Zip share price rose by 110% in FY25. Today, it's trading at $3.35, down 2.33%.

UBS gives Zip shares a buy rating with a 12-month price target of $3.40.

On The Bull, Andrew Wielandt from DP Wealth Advisory also has a buy rating but says the ASX 200 financial share is "higher risk".

Temple & Webster Group Ltd (ASX: TPW)

The online furniture retailer outperformed every other ASX 200 retail share in FY25.

The Temple & Webster share price rose by 127% in FY25. Today, it's trading at $26.21, up 1.59%.

Amid a retail sales surge in June, Morgan Stanley gives Temple & Webster an overweight rating and $28 price target.

Pro Medicus Limited (ASX: PME)

The Pro Medicus share price rose by 99% in FY25. On Friday, the stock is trading at $309.83, down 3.13%.

Pro Medicus shares have continued their rise following news of two major contracts in the US last month.

Samy Sriram, Markets Analyst at online trading platform Stake, says Pro Medicus's ascension into the S&P/ASX 50 (ASX: XFL) has "boosted its institutional profile".

Macquarie has a neutral rating on this ASX 200 healthcare share with a price target of $258.90.

Morgan Stanley is far more bullish. It has an overweight rating and a $320 price target.

Evolution Mining Ltd (ASX: EVN)

Gold miners had a fantastic run in FY25, and Evolution was no exception.

The Evolution Mining share price ascended 123% in FY25. Today, it's trading at $7.63, up 1.67%.

Morgans placed a trim rating on the ASX 200 gold share last month after the miner released its quarterly report.

Eagers Automotive Ltd (ASX: APE)

The Eagers Automotive share price ascended 66% in FY25. Today, it's trading at $20.65, up 0.24.

Macquarie has an outperform rating on Eagers Automotive shares with a 12-month price target of $20.35. 

Genesis Minerals Ltd (ASX: GMD)

The Genesis Minerals share price rose 145% in FY25. On Friday, it's trading at $4.03, up 0.5%.

Macquarie has an outperform rating on Genesis Minerals with a 12-month price target of $5.50.

JB Hi-Fi Limited (ASX: JBH)

The JB Hi-Fi share price soared by 80% in FY25. Today, it's trading at $117.20, up 0.67%.

Bell Potter has a buy rating and a $114 price target on this ASX 200 retail share.

In a note, the broker said:

We view the retailer as being able to support a higher multiple as we see a sizable upside from the AI driven upgrade cycle/replacement cycle of devices purchased during COVID-peak and given the similarities of JBH and other low gross margin yet high-earnings quality retailers globally.

Mesoblast Ltd (ASX: MSB)

The Mesoblast share price lifted 67% in FY25 and rocketed further last month after an update.

Today, Mesoblast shares are $2.33, down 1.48%.

Bell Potter has maintained a speculative buy rating on this ASX biotech share with a $3.50 price target.

Life360 Inc (ASX: 360)

The Life360 share price rose by 97% in FY25. Life360 shares are currently $38.18, down 3.56%.

The family location app provider was the tech sector's second-best performer last financial year.

Citi has a buy rating on this ASX 200 tech share with a price target of $46.20.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10